114 related articles for article (PubMed ID: 33347281)
1. Synthesis, Pharmacological, and Biological Evaluation of 2-Furoyl-Based MIF-1 Peptidomimetics and the Development of a General-Purpose Model for Allosteric Modulators (ALLOPTML).
Sampaio-Dias IE; Rodríguez-Borges JE; Yáñez-Pérez V; Arrasate S; Llorente J; Brea JM; Bediaga H; Viña D; Loza MI; Caamaño O; García-Mera X; González-Díaz H
ACS Chem Neurosci; 2021 Jan; 12(1):203-215. PubMed ID: 33347281
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Pharmacological, and Biological Evaluation of MIF-1 Picolinoyl Peptidomimetics as Positive Allosteric Modulators of D
Sampaio-Dias IE; Silva-Reis SC; García-Mera X; Brea J; Loza MI; Alves CS; Algarra M; Rodríguez-Borges JE
ACS Chem Neurosci; 2019 Aug; 10(8):3690-3702. PubMed ID: 31347842
[TBL] [Abstract][Full Text] [Related]
3. Perturbation Theory/Machine Learning Model of ChEMBL Data for Dopamine Targets: Docking, Synthesis, and Assay of New l-Prolyl-l-leucyl-glycinamide Peptidomimetics.
Ferreira da Costa J; Silva D; Caamaño O; Brea JM; Loza MI; Munteanu CR; Pazos A; García-Mera X; González-Díaz H
ACS Chem Neurosci; 2018 Nov; 9(11):2572-2587. PubMed ID: 29791132
[TBL] [Abstract][Full Text] [Related]
4. Discovery of New Potent Positive Allosteric Modulators of Dopamine D
Sampaio-Dias IE; Reis-Mendes A; Costa VM; García-Mera X; Brea J; Loza MI; Pires-Lima BL; Alcoholado C; Algarra M; Rodríguez-Borges JE
J Med Chem; 2021 May; 64(9):6209-6220. PubMed ID: 33861612
[TBL] [Abstract][Full Text] [Related]
5. Novel l-prolyl-l-leucylglycinamide (PLG) tripeptidomimetics based on a 2-azanorbornane scaffold as positive allosteric modulators of the D
Sampaio-Dias IE; Sousa CA; García-Mera X; Ferreira da Costa J; Caamaño O; Rodríguez-Borges JE
Org Biomol Chem; 2016 Nov; 14(47):11065-11069. PubMed ID: 27830864
[TBL] [Abstract][Full Text] [Related]
6. PTML Combinatorial Model of ChEMBL Compounds Assays for Multiple Types of Cancer.
Bediaga H; Arrasate S; González-Díaz H
ACS Comb Sci; 2018 Nov; 20(11):621-632. PubMed ID: 30240186
[TBL] [Abstract][Full Text] [Related]
7. Transformation of Pro-Leu-Gly-NH2 peptidomimetic positive allosteric modulators of the dopamine D2 receptor into negative modulators.
Bhagwanth S; Mishra S; Daya R; Mah J; Mishra RK; Johnson RL
ACS Chem Neurosci; 2012 Apr; 3(4):274-84. PubMed ID: 22860194
[TBL] [Abstract][Full Text] [Related]
8. Multioutput Perturbation-Theory Machine Learning (PTML) Model of ChEMBL Data for Antiretroviral Compounds.
Vásquez-Domínguez E; Armijos-Jaramillo VD; Tejera E; González-Díaz H
Mol Pharm; 2019 Oct; 16(10):4200-4212. PubMed ID: 31426639
[TBL] [Abstract][Full Text] [Related]
9. Preclinical pharmacokinetic and toxicological evaluation of MIF-1 peptidomimetic, PAOPA: examining the pharmacology of a selective dopamine D2 receptor allosteric modulator for the treatment of schizophrenia.
Tan ML; Basu D; Kwiecien JM; Johnson RL; Mishra RK
Peptides; 2013 Apr; 42():89-96. PubMed ID: 23416534
[TBL] [Abstract][Full Text] [Related]
10. PTML Model for Selection of Nanoparticles, Anticancer Drugs, and Vitamins in the Design of Drug-Vitamin Nanoparticle Release Systems for Cancer Cotherapy.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; Montemore MM; González-Díaz H
Mol Pharm; 2020 Jul; 17(7):2612-2627. PubMed ID: 32459098
[TBL] [Abstract][Full Text] [Related]
11. Big Data Challenges Targeting Proteins in GPCR Signaling Pathways; Combining PTML-ChEMBL Models and [
Diez-Alarcia R; Yáñez-Pérez V; Muneta-Arrate I; Arrasate S; Lete E; Meana JJ; González-Díaz H
ACS Chem Neurosci; 2019 Nov; 10(11):4476-4491. PubMed ID: 31618004
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of novel pyridine based PLG tripeptidomimetics.
Saitton S; Del Tredici AL; Saxin M; Stenström T; Kihlberg J; Luthman K
Org Biomol Chem; 2008 May; 6(9):1647-54. PubMed ID: 18421399
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide.
Khalil EM; Ojala WH; Pradhan A; Nair VD; Gleason WB; Mishra RK; Johnson RL
J Med Chem; 1999 Feb; 42(4):628-37. PubMed ID: 10052970
[TBL] [Abstract][Full Text] [Related]
14. Designing nanoparticle release systems for drug-vitamin cancer co-therapy with multiplicative perturbation-theory machine learning (PTML) models.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva E; González-Díaz H
Nanoscale; 2019 Nov; 11(45):21811-21823. PubMed ID: 31691701
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor.
Fisher A; Mann A; Verma V; Thomas N; Mishra RK; Johnson RL
J Med Chem; 2006 Jan; 49(1):307-17. PubMed ID: 16392815
[TBL] [Abstract][Full Text] [Related]
16. Stapling Amantadine to Melanostatin Neuropeptide: Discovery of Potent Positive Allosteric Modulators of the D
Silva-Reis SC; Correia XC; Costa-Almeida HF; Pires-Lima BL; Maronde D; Costa VM; García-Mera X; Cruz L; Brea J; Loza MI; Rodríguez-Borges JE; Sampaio-Dias IE
ACS Med Chem Lett; 2023 Dec; 14(12):1656-1663. PubMed ID: 38116429
[TBL] [Abstract][Full Text] [Related]
17. Development of peptidomimetic ligands of Pro-Leu-Gly-NH(2) as allosteric modulators of the dopamine D(2) receptor.
Bhagwanth S; Mishra RK; Johnson RL
Beilstein J Org Chem; 2013; 9():204-14. PubMed ID: 23400263
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and dopamine receptor modulating activity of diketopiperazine peptidomimetics of L-prolyl-L-leucylglycinamide.
Baures PW; Ojala WH; Costain WJ; Ott MC; Pradhan A; Gleason WB; Mishra RK; Johnson RL
J Med Chem; 1997 Oct; 40(22):3594-600. PubMed ID: 9357526
[TBL] [Abstract][Full Text] [Related]
19. PTML Model of ChEMBL Compounds Assays for Vitamin Derivatives.
Santana R; Zuluaga R; Gañán P; Arrasate S; Onieva Caracuel E; González-Díaz H
ACS Comb Sci; 2020 Mar; 22(3):129-141. PubMed ID: 32011854
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and allosteric modulation of the dopamine receptor by peptide analogs of L-prolyl-L-leucyl-glycinamide (PLG) modified in the L-proline or L-proline and L-leucine scaffolds.
Ferreira da Costa J; Caamaño O; Fernández F; García-Mera X; Sampaio-Dias IE; Brea JM; Cadavid MI
Eur J Med Chem; 2013 Nov; 69():146-58. PubMed ID: 24013414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
